Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Targets of Ferroptosis in Hepatocellular Carcinoma
Hao Liao, Juanyi Shi, Kai Wen, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 985-996
Open Access | Times Cited: 24

Showing 24 citing articles:

APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy
Yu Du, Yu Zhou, Xinyu Yan, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 4, pp. 431-446
Closed Access | Times Cited: 23
Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation
Dino Bekric, Matthias Ocker, Christian Mayr, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1826-1826
Open Access | Times Cited: 42
IGF2BP3-NRF2 axis regulates ferroptosis in hepatocellular carcinoma
Zhihua Lu, Hao Yang, Yuting Shao, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 627, pp. 103-110
Closed Access | Times Cited: 40
Autophagy activation is required for N6-methyladenosine modification to regulate ferroptosis in hepatocellular carcinoma
Yujia Li, Mei Guo, Yangling Qiu, et al.
Redox Biology (2023) Vol. 69, pp. 102971-102971
Open Access | Times Cited: 28
Crosstalk between Endoplasmic Reticulum Stress and Ferroptosis in Liver Diseases
Meiling Huang, Yao Wang, Xiaowei Wu, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 6, pp. 221-221
Open Access | Times Cited: 9
Puerarin Ameliorates the Ferroptosis in Diabetic Liver Injure Through the JAK2/STAT3 Pathway Inhibition Based on Network Pharmacology and Experimental Validation
Xiao-Xu Fan, Shuangqiao Liu, Jing Yu, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 737-757
Open Access | Times Cited: 1
Silenced LINC01134 Enhances Oxaliplatin Sensitivity by Facilitating Ferroptosis Through GPX4 in Hepatocarcinoma
Xiaofeng Kang, Yan Huo, Songhao Jia, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 37
Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1166-1166
Open Access | Times Cited: 21
Iron as a therapeutic target in chronic liver disease
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki
World Journal of Gastroenterology (2023) Vol. 29, Iss. 4, pp. 616-655
Open Access | Times Cited: 18
LncRNA PELATON, a Ferroptosis Suppressor and Prognositic Signature for GBM
Haijuan Fu, Zhaoyu Zhang, Danyang Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 27
Apoptosis, Pyroptosis, and Ferroptosis Conspiringly Induce Immunosuppressive Hepatocellular Carcinoma Microenvironment and γδ T-Cell Imbalance
Yi Hu, Dan Chen, Minjing Hong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
E3 ubiquitin ligase CHIP interacts with transferrin receptor 1 for degradation and promotes cell proliferation through inhibiting ferroptosis in hepatocellular carcinoma
Miaomiao Shao, Kangwei Qi, Lanxin Wang, et al.
Cellular Signalling (2024) Vol. 118, pp. 111148-111148
Closed Access | Times Cited: 5
Glycolysis-Related LINC02432/Hsa-miR-98–5p/HK2 Axis Inhibits Ferroptosis and Predicts Immune Infiltration, Tumor Mutation Burden, and Drug Sensitivity in Pancreatic Adenocarcinoma
Peng Tan, Mo Li, Zhuoran Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Epigenetic and Post-Translational Modifications in Ferroptosis Regulation and Hepatocellular Carcinoma: New Frontiers in Therapeutic Targeting
Soheil Bolandi, Samaneh Dodge, Zahra Zahed, et al.
Pathology - Research and Practice (2025), pp. 155991-155991
Closed Access
Construction of a prognostic model for HCC based on ferroptosis-related lncRNAs expression and its potential to predict the response and irAEs of immunotherapy
Liangbo Dong, Shengnan Zhou, Xuesong Bai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Distinct Types of Cell Death and Implications in Liver Diseases: An Overview of Mechanisms and Application
Yukun Wang, Chunxia Shi, Jin Guo, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 8
Excessive SOX8 reprograms energy and iron metabolism to prime hepatocellular carcinoma for ferroptosis
Xue Yang, Chun Gu, Jingshu Cai, et al.
Redox Biology (2023) Vol. 69, pp. 103002-103002
Open Access | Times Cited: 8
The Emerging Role of Ferroptosis in Liver Cancers
Arianna Casini, Stefano Leone, Rosa Vaccaro, et al.
Life (2022) Vol. 12, Iss. 12, pp. 2128-2128
Open Access | Times Cited: 14
Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer
Yinghui Li, Cui-Yun Liu, Bo Fang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Gentian violet induces apoptosis and ferroptosis via modulating p53 and MDM2 in hepatocellular carcinoma.
Jingyi Chen, Fangxin Zhao, Hongxin Yang, et al.
PubMed (2022) Vol. 12, Iss. 7, pp. 3357-3372
Closed Access | Times Cited: 9
OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism
Jie Wen, Abudureyimujiang Aili, Yao Xue Yan, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Ferroptosis in Cancer Immunotherapy—Implications for Hepatocellular Carcinoma
Johanna Kusnick, Alix Bruneau, Frank Tacke, et al.
Immuno (2022) Vol. 2, Iss. 1, pp. 185-217
Open Access | Times Cited: 6
Disputes and Challenges of Immune Checkpoint Inhibitors in Gastrointestinal Cancers
Hongwei Yao, Wen G. Jiang, Zhi‐Chun Gu, et al.
Frontiers research topics (2024)
Open Access
LncRNA <i>Pelaton</i>, a Ferroptosis Suppressor and Prognositic Signature for GBM
Haijuan Fu, Zhaoyu Zhang, Zuping Zhang, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 1
Page 1

Scroll to top